BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/10/2021 7:23:16 AM | Browse: 259 | Download: 321
 |
Received |
|
2021-03-29 04:46 |
|
Peer-Review Started |
|
2021-03-29 04:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-28 22:37 |
|
Revised |
|
2021-05-08 02:05 |
|
Second Decision |
|
2021-08-13 03:02 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-08-13 03:15 |
|
Articles in Press |
|
2021-08-13 03:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-06 02:59 |
|
Publish the Manuscript Online |
|
2021-09-10 07:23 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Case Report |
| Article Title |
Chronic active Epstein-Barr virus infection treated with PEG-aspargase: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
De-Li Song, Jing-Shi Wang, Lei-Lei Chen and Zhao Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81871633 |
| Beijing Natural Science Foundation |
7181003 |
| Beijing Municipal Administration of Hospitals’ Ascent Plan |
DFL20180101 |
|
| Corresponding Author |
Zhao Wang, MD, Professor, Department of Hematology, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong An Road, Xicheng District, Beijing 100050, China. wangzhao@ccmu.edu.cn |
| Key Words |
Chronic active Epstein-Barr virus infection; PEG-aspargase; Chemotherapy; L-asparaginase; Case report |
| Core Tip |
Chronic active Epstein-Barr virus (EBV) infection may lead to fatal diseases, including EBV-positive lymphoproliferative disorders, lymphomas, and lymphohistiocytosis. We present a chronic active EBV (CAEBV) patient who was treated with PEG-aspargase and achieved decreased load of EBV-DNA. PEG-aspargase requires further investigation as a chemotherapy drug for CAEBV to reduce the load of EBV-DNA. |
| Publish Date |
2021-09-10 07:23 |
| Citation |
Song DL, Wang JS, Chen LL, Wang Z. Chronic active Epstein-Barr virus infection treated with PEG-aspargase: A case report. World J Clin Cases 2021; 9(26): 7845-7849 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i26/7845.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i26.7845 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
